Home›Companies›Biotech & Pharma›Amplica Bio

Amplica Bio, Inc.

Develops biological medicines for difficult disease targets.

No LinkedIn page we could confirm. Why?
Updated Nov 9, 2026·Latest SEC filing Sep 11, 2026·Suggest an edit

About Amplica Bio

Amplica Bio is a private company based in Wilmington, Delaware, incorporated in 2026 in Delaware. It has reported $30,000 raised in one offering on Form D since September 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 2, 2026Sep 11, 2026$30,000target not set1$30,000Equity, Simple Agreement for Future Equity (SAFE)Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Amplica Bio's Form D filed Sep 11, 2026.

KG
Kaustav Gopinathan
Executive officer
KM
Kush Mehta
Chief Business Officer and director

Sources

  1. SECAmplica Bio, Inc. filing history